The authors suggest the potential role of adiponectin as a new tumor marker in pancreatic cancer and in differentiating diagnoses between pancreatic cancer and chronic pancreatitis [106].Likewise, in Oldfield et al.’sopinion, adiponectin could be useful in screening for PDAC in individuals newly diagnosed with T2DM [47]. The gene discussed is ADIPOQ; the disease is chronic pancreatitis.